Riverbridge Partners’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.83M Sell
281,219
-208,523
-43% -$4.61M 0.16% 89
2026
Q1
$11.4M Sell
489,742
-38,836
-7% -$1.21M 0.28% 77
2025
Q4
$23.4M Sell
528,578
-26,606
-5% -$1.49M 0.44% 67
2025
Q3
$40.6M Sell
555,184
-383,436
-41% -$25M 0.69% 50
2025
Q2
$57.6M Sell
938,620
-142,693
-13% -$7.96M 0.93% 38
2025
Q1
$62.7M Sell
1,081,313
-104,414
-9% -$6.59M 1.01% 35
2024
Q4
$63.3M Sell
1,185,727
-97,659
-8% -$4.78M 0.86% 45
2024
Q3
$55.9M Sell
1,283,386
-44,939
-3% -$1.5M 0.75% 51
2024
Q2
$37.2M Buy
+1,328,325
New +$35M 0.5% 66

Other funds holding DOCS

Riverbridge Partners's DOCS Position: Q2 2026 in Review

Riverbridge Partners reduced its Doximity (DOCS) stake by 43% in Q2 2026, selling an estimated $4.61M and leaving 281,219 shares worth $5.83M. The position accounts for 0.16% of the portfolio, ranked #89.

Riverbridge Partners first reported a position in DOCS in Q2 2024 and has held it in 9 quarters since. The position peaked at $63.3M in Q4 2024. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Riverbridge Partners held 281,219 shares of Doximity worth $5.83M as of Q2 2026.
  • Riverbridge Partners sold 208,523 Doximity shares in Q2 2026, an estimated $4.61M.
  • Doximity made up 0.16% of Riverbridge Partners's portfolio in Q2 2026, its #89 holding.
  • Riverbridge Partners first reported a position in Doximity in Q2 2024 and has held it in 9 quarters since.
  • Riverbridge Partners's Doximity position peaked at $63.3M in Q4 2024.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Riverbridge Partners's 13F filing for Q2 2026, filed 13 Jul 2026.